Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The proteasome inhibitor bortezomib attenuates renal fibrosis in mice via the suppression of TGF-β1
Moko Zeniya, Takayasu Mori, Naofumi Yui, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits
Ramnika Gumber, Jordana B. Cohen, Matthew B. Palmer, et al.
Kidney International (2018) Vol. 94, Iss. 1, pp. 199-205
Open Access | Times Cited: 117
MicroRNA-214 promotes chronic kidney disease by disrupting mitochondrial oxidative phosphorylation
Mi Bai, Huimei Chen, Dan Ding, et al.
Kidney International (2019) Vol. 95, Iss. 6, pp. 1389-1404
Open Access | Times Cited: 88
Aristolochic Acid-Induced Nephrotoxicity: Molecular Mechanisms and Potential Protective Approaches
Etienne Empweb Anger, Feng Yu, Ji Li
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1157-1157
Open Access | Times Cited: 78
Regulation of myofibroblast dedifferentiation in pulmonary fibrosis
Xuetao Ju, Kai Wang, Congjian Wang, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 10
Bortezomib attenuates renal interstitial fibrosis in kidney transplantation via regulating the EMT induced by TNF‐α‐Smurf1‐Akt‐mTOR‐P70S6K pathway
Jiajun Zhou, Hong Cheng, Zijie Wang, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 23, Iss. 8, pp. 5390-5402
Open Access | Times Cited: 50
Protective Effects of Melatonin Against Aristolochic Acid-Induced Nephropathy in Mice
Jung‐Yeon Kim, Jaechan Leem, Eon Ju Jeon
Biomolecules (2019) Vol. 10, Iss. 1, pp. 11-11
Open Access | Times Cited: 47
Renal TNFα activates the WNK phosphorylation cascade and contributes to salt-sensitive hypertension in chronic kidney disease
Taisuke Furusho, Eisei Sohara, Shintaro Mandai, et al.
Kidney International (2020) Vol. 97, Iss. 4, pp. 713-727
Open Access | Times Cited: 40
Targeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management
Eslam E. Abd El-Fattah, Amr Y. Zakaria
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 24
Liquid biopsy biomarkers of renal interstitial fibrosis based on urinary exosome
Chunyan Lv, Ziyi Zhao, Yang Tianlin, et al.
Experimental and Molecular Pathology (2018) Vol. 105, Iss. 2, pp. 223-228
Closed Access | Times Cited: 36
Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer
Ok-Seon Kwon, Haeseung Lee, Hyeon-Joon Kong, et al.
Oncogene (2020) Vol. 39, Iss. 23, pp. 4567-4580
Open Access | Times Cited: 32
APP-CD74 axis mediates endothelial cell-macrophage communication to promote kidney injury and fibrosis
Bin Liu, Faping Li, Yu-Xiong Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Organelle stress and alterations in interorganelle crosstalk during liver fibrosis
Saloni Sinha, Nora Hassan, Robert E. Schwartz
Hepatology (2023) Vol. 79, Iss. 2, pp. 482-501
Closed Access | Times Cited: 9
Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment
Sabine Karam, Mohammad Haidous, Iman Abou Dalle, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 183, pp. 103926-103926
Closed Access | Times Cited: 8
Status and role of the ubiquitin–proteasome system in renal fibrosis
Yizhen Chen, Rong Dai, Meng Cheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117210-117210
Open Access | Times Cited: 2
Exosomal miR‐21‐5p derived from multiple myeloma cells promote renal epithelial–mesenchymal transition through targeting TGF‐β/SMAD7 signalling pathway
Liping Liu, Langni Liu, Rui Liu, et al.
Clinical and Experimental Pharmacology and Physiology (2023) Vol. 50, Iss. 9, pp. 711-718
Open Access | Times Cited: 6
Altered proteasome function in right ventricular hypertrophy
Tanja Heitmeier, Akylbek Sydykov, Christina Lukas, et al.
Cardiovascular Research (2019)
Open Access | Times Cited: 16
Proteasome Inhibitors Bortezomib and Carfilzomib Stimulate the Transport Activity of Human Organic Anion Transporter 1
Yunzhou Fan, Guofeng You
Molecular Pharmacology (2020) Vol. 97, Iss. 6, pp. 384-391
Open Access | Times Cited: 16
Bortezomib Inhibits Lung Fibrosis and Fibroblast Activation without Proteasome Inhibition
Loka R. Penke, Jennifer M. Speth, Scott H. Wettlaufer, et al.
American Journal of Respiratory Cell and Molecular Biology (2021) Vol. 66, Iss. 1, pp. 23-37
Open Access | Times Cited: 12
Protein phosphatase Mg 2+ /Mn 2+ dependent‐1A and PTEN deregulation in renal fibrosis: Novel mechanisms and co‐dependency of expression
Jiaqi Tang, Roel Goldschmeding, Rohan Samarakoon, et al.
The FASEB Journal (2019) Vol. 34, Iss. 2, pp. 2641-2656
Closed Access | Times Cited: 13
Bortezomib limits renal allograft interstitial fibrosis by inhibiting NF-κB/TNF-α/Akt/mTOR/P70S6K/Smurf2 pathway via IκBα protein stabilization
Chuanjian Suo, Zeping Gui, Zijie Wang, et al.
Clinical Science (2020) Vol. 135, Iss. 1, pp. 53-69
Open Access | Times Cited: 11
Bortezomib alleviates antibody‐mediated rejection in kidney transplantation by facilitating Atg5 expression
Hong Cheng, Bin Xu, Lijie Zhang, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 23, pp. 10939-10949
Open Access | Times Cited: 10
Bortezomib restrains M2 polarization and reduces CXCL16-associated CXCR6+CD4 T cell chemotaxis in bleomycin-induced pulmonary fibrosis
Ting Zhou, Lan Lin, Yawen Zhan, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Genome-wide CRISPR-based screen identifies E2F transcription factor 1 as a Regulator and therapeutic target of aristolochic acid-induced nephrotoxicity
Ziqi Liu, Huan Gao, Guoliang Li, et al.
Environment International (2024) Vol. 195, pp. 109234-109234
Open Access | Times Cited: 1
Dually Efficacious Medicine Against Fibrosis and Cancer
Daohong Chen
Medical Sciences (2019) Vol. 7, Iss. 3, pp. 41-41
Open Access | Times Cited: 9
Time Course of the Effects of Buxin Yishen Decoction in Promoting Heart Function and Inhibiting the Progression of Renal Fibrosis in Myocardial Infarction Caused Type 2 Cardiorenal Syndrome Rats
Qi Qiu, Jinglin Cao, Yong Wang, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top